Alkyl Amines Chemicals Limited

Alkyl Amines Chemicals Limited

ALKYLAMINE.NS
Alkyl Amines Chemicals LimitedIN flagNational Stock Exchange of India
1,836.80
INR
+58.10
- -
93.94BMarket Cap
Alkyl Amines Chemicals Limited
ALKYLAMINE.NS
(National Stock Exchange of India)

Recent

price

1,836.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
45.63
55.2
70.4
43.17
45.89
92.68
95.83
118.65
163.21
190.83
239.77
298.38
324.29
277.61
307.42
300.34
308.55
Revenue per Share
2.74
3.45
4.75
4.24
4.43
9.81
10.16
12.94
16.89
42.22
57.9
44.04
44.75
29.13
36.4
35.2
36.51
Basic EPS, GAAP
0.84
4.09
-0.31
2.04
1.96
12.97
-0.49
-6.68
14.74
21.83
40.74
-8.28
-10.77
29.83
42.13
21.54
- -
Free Cash Flow per Basic Share
0.7
0.7
0.93
0.58
0.94
6.74
- -
2.41
3.38
8.68
8
6
10
10
10
10
- -
Dividend per Share
2
11.09
14.2
9.98
13
31.06
41.13
51.68
65.02
95.55
152.03
182.85
217.17
235.91
262.12
2
- -
Book Value per Share
16.43
18.91
22.46
14.51
17.9
40.41
49.93
60.43
74.16
104.93
155.07
193.49
228.08
247.17
273.69
299.29
- -
Tangible Book Value per Share
51
51
51
102
102
51
51
51
51
51
51
51
51
51
51
51
51
Basic Weighted Avg Shares
2,327
2,815
3,590
4,403
4,680
4,726
4,886
6,050
8,322
9,730
12,231
15,236
16,569
14,190
15,718
15,358
15,777
Sales/Revenue/Turnover
3.24
13.21
13.61
17.38
16.64
17.79
16.63
17.09
17.04
23.81
33.17
19.17
18.32
13.85
13.99
13.87
13.76
Operating Margin (%)
92
89
100
97
114
129
129
154
233
269
291
348
452
589
712
717
714
Depreciation Expense
140
176
242
433
451
500
518
660
861
2,153
2,953
2,249
2,287
1,489
1,861
1,800
1,867
Net Income, GAAP
26.83
27.18
33.21
33.42
32.11
31.2
31.27
32.3
35.04
17.11
26.29
25.56
25.9
26.47
25.15
26.07
25.05
Effective Tax Rate (%)
6
6.25
6.75
9.83
9.64
10.59
10.6
10.91
10.35
22.12
24.15
14.76
13.8
10.49
11.84
11.72
11.83
Profit Margin (%)
890
189
360
553
520
527
644
588
643
1,403
2,461
2,097
1,465
2,159
3,850
4,569
- -
Working Capital
- -
520
600
648
560
448
662
1,082
790
486
222
5
18
19
12
4
- -
LT Debt
852
980
1,162
1,500
1,843
2,074
2,558
3,090
3,791
5,366
7,925
9,898
11,689
12,671
14,025
15,334
- -
Total Equity
4.04
17.65
13.5
18.1
17.07
18.18
16.15
16.22
17.85
32.96
40.91
23.48
19.82
11.43
12.29
10.7
- -
Return on Invested Capital (%)
32.1
26.18
15.72
21.47
19.79
20.55
18.9
18.44
20.17
41.66
42.83
25.49
21.42
12.61
14.63
26.65
304.98
Return on Capital (%)
136.74
52.72
37.56
49.68
38.51
34.39
28.16
27.89
28.94
52.59
46.78
26.32
22.38
12.86
14.62
26.66
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
43
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
12
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
51
- -
Market Capitalization
90,089
82,735
121,078

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
6,301
- -
Cash, Cash Equivalents & STI
- -
2,028
- -
Accounts Receivable, Net
- -
2,302
- -
Inventories
- -
1,648
- -
Total Current Liabilities
- -
2,452
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
43
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.74%
14.28%
9.33%
Free Cash Flow
49.07%
-94.95%
-48.87%
Net Income, GAAP
21.33%
-7.07%
-3.28%
Sales/Revenue/Turnover
13.48%
5.49%
-2.29%
Total Cash Common Dividend
- -
8.39%
0.04%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,098
3,522
3,220
3,350
14,190
2025
3,997
4,149
3,712
3,860
15,718
2026
4,055
3,540
3,869
- -
15,358

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9.74
5.33
6.54
- -
29.13
2025
9.56
9.28
8.56
9
36.4
2026
9.67
8.26
8.87
- -
35.2

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10
2025
- -
- -
- -
- -
10
2026
- -
- -
- -
- -
10
Business
Alkyl Amines Chemicals Limited manufactures and supplies aliphatic amines, amine derivatives, and specialty chemicals primarily for the pharmaceutical, agrochemical, rubber chemical, water treatment, and surfactant industries. The company offers an extensive portfolio exceeding 100 products, including methylamines (such as monomethylamine, dimethylamine, trimethylamine), ethylamines (such as monoethylamine, diethylamine, triethylamine), propylamines (including isopropylamine, n-propylamine), butylamines (such as monobutylamine, dibutylamine), cyclohexylamines, ethylhexylamines, furfurylamines; amine derivatives like dimethylamine hydrochloride, diethylamine hydrochloride, diethylhydroxylamine; and specialty chemicals including synthetic acetonitrile, in which it holds global leadership positions; along with custom synthesis, contract research and development, toll manufacturing, and fine chemical production services. Founded in 1979 and headquartered in Navi Mumbai, India, with manufacturing facilities at Patalganga, Kurkumbh, and Dahej, the company operates in India and exports internationally. Recent developments include the commissioning of a second hydrogen plant and a DEK plant at Kurkumbh in 2022, along with a captive solar power plant at Manwath; commercial production commencement at Kurkumbh in 2023; and in November 2024, board approval for a Rs 115-150 crore investment to establish a new specialty chemicals plant at Dahej, Gujarat, expanding capacity from 3,000 to 4,000 metric tons per annum over 15-50 months to meet rising domestic and export demand while reducing imports.